This topic contains a solution. Click here to go to the answer
« previous next »

Author Question: The patient has a diagnosis of multiple sclerosis and is taking the drug interferon beta-1a (Rebif). ... (Read 82 times)

jake

  • Hero Member
  • *****
  • Posts: 538
on: Jul 23, 2018
The patient has a diagnosis of multiple sclerosis and is taking the drug interferon beta-1a (Rebif). The patient takes this drug by subcutaneous injection three times a week. The dosage is 44 mcg per injection.
 
  If the patient takes an injection on Monday, how much of the drug would still be in the patient's system when she takes her next injection on Wednesday, assuming the half-life of the drug is 24 hours? A) 22 mcg
  B) 16.5 mcg
  C) 11 mcg
  D) 5.5 mcg

Question 2

A patient diagnosed with bipolar disorder is to be discharged home in 48 hours. The nurse has completed patient teaching regarding the use of lithium. What statement by the patient indicates an understanding of their responsibility?
 
  A) I will increase my salt intake.
  B) I will increase my fluid intake.
  C) I will decrease my salt intake.
  D) I will decrease my fluid intake.


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

lkoler

  • Sr. Member
  • ****
  • Posts: 358
Reply #1 on: Jul 23, 2018
Answer to Question 1

C
Feedback:
The half-life of a drug is the time it takes for the amount of drug in the body to decrease to 1 half the peak level it previously achieved. On Tuesday, there would be 22 mcg remaining in the body, so option A is incorrect. On Wednesday 11 mcg would remain, so option C is the correct answer. At 12 hours before taking the next dose on Wednesday, there would be 16.5 mcg remaining. If the injection were not taken on Wednesday, 12 hours after the dose was due, there would be 5.5 mcg remaining.

Answer to Question 2

B
Feedback:
To maintain a therapeutic lithium level, the patient must increase fluids. A decrease in consumption of fluids can lead to toxicity. An increase in salt intake can lead to lithium excretion and a decrease in effectiveness. A decrease in salt intake can cause retention, also leading to toxicity. Adequate salt intake is necessary to keep serum levels in therapeutic range but need not be increased or decreased.


jake

  • Member
  • Posts: 538
Reply 2 on: Jul 23, 2018
Wow, this really help

juliaf

  • Member
  • Posts: 344
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

« previous next »
 

Did you know?

A cataract is a clouding of the eyes' natural lens. As we age, some clouding of the lens may occur. The first sign of a cataract is usually blurry vision. Although glasses and other visual aids may at first help a person with cataracts, surgery may become inevitable. Cataract surgery is very successful in restoring vision, and it is the most frequently performed surgery in the United States.

Did you know?

The senior population grows every year. Seniors older than 65 years of age now comprise more than 13% of the total population. However, women outlive men. In the 85-and-over age group, there are only 45 men to every 100 women.

Did you know?

Studies show that systolic blood pressure can be significantly lowered by taking statins. In fact, the higher the patient's baseline blood pressure, the greater the effect of statins on his or her blood pressure.

Did you know?

Children of people with alcoholism are more inclined to drink alcohol or use hard drugs. In fact, they are 400 times more likely to use hard drugs than those who do not have a family history of alcohol addiction.

Did you know?

Medication errors are three times higher among children and infants than with adults.

) Subcutaneous drug administration: (b) the administration site is prepped ) Subcutaneous drug administration: (b) the administration site is prepped
A nurse communicates with her non–English-speaking patient through an interpreter A nurse communicates with her non–English-speaking patient through an interpreter
Diagnosis for Major Depression Diagnosis for Major Depression
Multiple sclerosis. Multiple sclerosis.
Tumor marker analysis of a patient with no evidence of disease monitored for tumor recurrence. The ... Tumor marker analysis of a patient with no evidence of disease monitored for tumor recurrence. The ...
A Drug’s Plateau Level A Drug’s Plateau Level
Video: Carbon fixing adaptations Animation

For a complete list of videos, visit our video library